Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Basware BAS1V Oct 18, 2019 19.06 -0.52   
 BBS-Bioactive Bone Substitutes BONEH Oct 18, 2019 2.08 0.00   
 Biohit B BIOBV Oct 18, 2019 2.79 -0.36   
 Bittium BITTI Oct 18, 2019 6.34 -0.63   
 CapMan CAPMAN Oct 18, 2019 1.92 -0.31   
 Cargotec CGCBV Oct 18, 2019 29.46 -1.21   
 Caverion CAV1V Oct 18, 2019 5.44 -0.18   
 Citycon CTY1S Oct 18, 2019 9.65 -1.68   
 Componenta CTH1V Oct 18, 2019 0.13 -1.12   
 Consti Yhtiöt CONSTI Oct 18, 2019 4.90 -0.41   
 Cramo CRA1V Oct 18, 2019 9.63 +1.80   
 Detection Technology DETEC Oct 18, 2019 20.25 +1.25   
 Digia DIGIA Oct 18, 2019 3.70 -0.80   
 Digitalist Group DIGIGR Oct 18, 2019 0.05 0.00   
 DNA DNA Oct 18, 2019 20.86 -0.19   
 Dovre Group DOV1V Oct 18, 2019 0.23 +0.43   
 EAB Group EAB Oct 18, 2019 2.86 0.00   
 Efecte PLC EFECTE Oct 18, 2019 4.55 -2.78   
 Efore EFO1V Oct 18, 2019 0.06 +0.34   
 Elecster A ELEAV Oct 18, 2019 8.80 -1.68   
 Elisa ELISA Oct 18, 2019 48.94 -0.99   
 Endomines ENDOM Oct 18, 2019 0.51 -1.94   
 Endomines ENDO Oct 18, 2019 5.50 -0.36   
 eQ EQV1V Oct 18, 2019 10.70 +0.94   
 Ericsson B ERIBR Oct 18, 2019 8.24 -0.70   
 Ericsson B ERICB Oct 18, 2019 88.74 -0.25   
 Etteplan ETTE Oct 18, 2019 8.74 -0.68   
 Evli Pankki EVLI Oct 18, 2019 8.40 0.00   
 Exel Composites EXL1V Oct 18, 2019 4.65 +0.65   
 F-Secure FSC1V Oct 18, 2019 2.77 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK